國家衛生研究院 NHRI:Item 3990099045/11058
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 854386      在线人数 : 604
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于NHRI管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/11058


    题名: Metformin and helicobacter pylori infection in patients with type 2 diabetes
    作者: Tseng, CH
    贡献者: National Institute of Environmental Health Sciences
    摘要: Patients with diabetes have an increased risk of gastric cancer (1,2), and metformin may protect against gastric cancer (3). This study investigated whether metformin might protect against Helicobacter pylori infection, an important risk factor of gastric cancer.The reimbursement database of Taiwan ’ s National Health Insurance was used. Disease diagnoses were based on the ICD-9-CM. Diabetes was coded 250. XX, and H. pylori infection was de fi ned by a diagnostic code of 041.86 plus receiving H. pylori eradication therapy (4). A propensity score (PS)-matched cohort (based on the Greedy 8 → 1 digit match algorithm) (3) comprised 16,060 metformin ever users and 16,060 metformin never users with new-onset diabetes, who were enrolled during 1999 – 2005 and followed up until the end of 2011. Patients with type 1 diabetes, cancer diagnoses, or H. pylori infections at entry or within 6 months of diabetes diagnosis, aged , 25 or . 75 years at entry, or with a follow-up duration , 6 months were not included. PS was derived from covariates including age, sex, occupation, living region, hypertension, dyslipidemia, obesity, nephropathy, eye disease, stroke, ischemic heart disease, peripheral arterial disease, chronic obstructive pulmonary disease, tobacco abuse, alcohol-related diagnoses, heart failure, gingival and periodontal diseases, pneumonia, osteoporosis, tuberculosis infection, disease of pancreas, diseases of esophagus, stomach, and duodenum, Epstein Barr virus infection, hepatitis B virus infection, hepatitis C virus infection, and use of insulin, sulfonylureas, meglitinides, acarbose, rosiglitazone, pioglitazone, ACE inhibitors/ angiotensin receptor blockers, calcium channel blockers, statins, fi brates, and aspirin. Hazard ratios (HRs) were estimated by Cox regression incorporated with the inverse probability of treatment weighting using PS (3). Standardized difference was calculated for each covariate, and a cutoff . 10% may indicate potential confounding (5).
    日期: 2018-02-01
    關聯: Diabetes Care. 2018 Apr;41(4):E42-E43.
    Link to: http://dx.doi.org/10.2337/dc17-2551
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0149-5992&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000428000000002
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85044511976
    显示于类别:[其他] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    PUB29437699.pdf523KbAdobe PDF188检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈